IL13RA2 targeted alpha particle therapy against glioblastomas.

about

Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy.

P2860

Q52632620-EAEBF715-D359-4B2F-B752-8B6B5E5DD048

P2860

IL13RA2 targeted alpha particle therapy against glioblastomas.

Item

http://www.wikidata.org/entity/Q38754116

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

IL13RA2 targeted alpha particle therapy against glioblastomas.

@en

type

Item

label

IL13RA2 targeted alpha particle therapy against glioblastomas.

@en

prefLabel

IL13RA2 targeted alpha particle therapy against glioblastomas.

@en

P1476

IL13RA2 targeted alpha particle therapy against glioblastomas.

@en

P2093

Ang Xuan

http://www.w3.org/2001/XMLSchema#string

Anirudh Sattiraju

http://www.w3.org/2001/XMLSchema#string

Darpan N Pandya

http://www.w3.org/2001/XMLSchema#string

Denise M Herpai

http://www.w3.org/2001/XMLSchema#string

Frankis G Almaguel

http://www.w3.org/2001/XMLSchema#string

Kiran Kumar Solingapuram Sai

http://www.w3.org/2001/XMLSchema#string

Thaddeus J Wadas

http://www.w3.org/2001/XMLSchema#string

Waldemar Debinski

http://www.w3.org/2001/XMLSchema#string

P2860

The blood-brain barrier: bottleneck in brain drug development

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma

Astrocyte-endothelial interactions at the blood-brain barrier

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy.

The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.

Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6

An interleukin 13 receptor α 2-specific peptide homes to human Glioblastoma multiforme xenografts.

Tumor therapy with targeted atomic nanogenerators.

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

The promise of targeted {alpha}-particle therapy.

P304

42997-43007

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.17792

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Akiva Mintz

P577

2017-05-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28562337

http://www.w3.org/2001/XMLSchema#string

P932

5522122

http://www.w3.org/2001/XMLSchema#string

IL13RA2 targeted alpha particle therapy against glioblastomas.

about

P2860

P2860

IL13RA2 targeted alpha particle therapy against glioblastomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932